糖尿病筛查与诊断方法的争议  

Dispute on screening and diagnostic methods of diabetes

作　　者：申红梅[1] 刘超[1] 

机构地区：[1]南京医科大学附属第一医院内分泌科,江苏南京210029

出　　处：《国际内科学杂志》2009年第11期656-660,共5页International Journal of Internal Medicine

摘　　要：及时筛查、正确诊断是糖尿病治疗的关键环节,近年来,不同国际组织美国糖尿病协会(ADA),WHO以及日本糖尿病协会(JDS)等在糖尿病诊断和筛查方面如糖尿病及糖尿病前期诊断切点的设立,糖化血红蛋白(HbA1C)在筛查与诊断中的应用价值等都存在争议。根据糖尿病发展的病理生理机制和基于血糖范围和糖尿病并发症危险的大规模的流行病学研究结果,设置适合各国人群的糖尿病诊断和筛查标准是当前亟待解决的问题。Timely screening and properly diagnosis are very important for the treatment of diabetes. Recently, different international organizations such as American Diabetes Association （ADA） , WHO, and Japan Diabetes Association（JDS） have controversies on the diagnostic and screening tests for diabetes, with regard to the cut-off point of blood glucose level and the practical value of hemoglobin Alc（HbA1C）. Seting up the diagnostic and screening criteria for target populations, based on the pathophysiology of diabetes and large-scale epidemiological studies, is necessary and utmost important.

关 键 词：糖尿病 诊断 筛查 争议 

分 类 号：R587.1[医药卫生—内分泌]